PATENT CLAIM ANALYSIS

Application Number: 15773512
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "189100"]

Abstract:
The present application provides immunotherapies for Hepatitis B virus infections. Provided herein are genetically modified arenaviral vectors suitable as vaccines for prevention and treatment of Hepatitis B virus infections. Also provided herein are pharmaceutical compositions and methods for the treatment of Hepatitis B virus infections. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of treating Hepatitis B virus infection.

Claim (Index 43):
The pharmaceutical composition of any one of  claims 33  to  42 , wherein the composition is suitable for intramuscular administration.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 93.0
- Lexical Diversity: 1.91429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15101363', '15580964', '14775484', '13037931', '12810382']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.782405185595504
- 35 USC 102 Novelty (BERT): 0.5529221863787465
- Combined Prediction Score: 0.7594568856738282
- Mean Citation Score: 372.36386
- Max Citation Score: 449.82828
- Similarity Product: 293.83602375359766

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test